Research Overviews

• 5-Amino-1MQ
  What 5-Amino-1MQ is, how it is studied as an NNMT inhibitor, and why it is research-stage. Prescription only; licensed provider evaluation required.
• AOD-9604 Peptide
  What AOD-9604 is, what animal studies reported, and why it is research-stage. Prescription only; licensed provider evaluation required.
• BPC-157 Peptide
  Plain-language overview of BPC-157: preclinical research, limited human data, and research-stage status. Prescription only; provider evaluation required.
• CJC-1295 and Ipamorelin
  How CJC-1295 and ipamorelin are studied as growth hormone secretagogues, and why both are not FDA approved. Prescription only; provider evaluation.
• Dihexa
  What dihexa is, what laboratory studies report, and why it is research-stage with no human data. Prescription only; provider evaluation required.
• DSIP (Delta Sleep-Inducing Peptide)
  What DSIP is, what small studies measured, and why it is research-stage. Not FDA approved. Prescription only; licensed provider evaluation required.
• Epithalon (Epitalon)
  What epithalon is and what lab studies report on telomerase and telomere length. Research-stage; not FDA approved. Prescription only; provider evaluation.
• GHK-Cu Copper Peptide
  What GHK-Cu is and what lab and skin studies report. Not FDA approved. Prescription only; provider evaluation required.
• Glutathione: What It Is and What Research Shows
  What glutathione is, what randomized trials report on body stores, and how a provider decides. Prescription only; licensed provider evaluation required.
• Kisspeptin
  What kisspeptin is and what human studies report on reproductive hormones. Research-stage; not FDA approved. Prescription only; provider evaluation.
• MK-677 (Ibutamoren)
  What MK-677 (ibutamoren) is, what a randomized trial in older adults found, and key safety signals. Not FDA approved. Prescription only; provider review.
• MOTS-c
  What MOTS-c is and what animal studies report on metabolism and exercise. Research-stage; not FDA approved. Prescription only; provider evaluation.
• NAD+: What It Is and What the Research Shows
  What NAD+ is, why researchers study NAD+ precursors, and what human trials report so far. Prescription only; licensed provider evaluation required.
• PT-141 (Bremelanotide)
  What PT-141 (bremelanotide) is, how it acts on melanocortin receptors, and its safety information. Compounded PT-141 is not FDA approved.
• Semaglutide
  What semaglutide is, how a GLP-1 receptor agonist works, its labeled side effects, and how compounded versions differ. Provider evaluation required.
• Semax and Selank
  What Semax and Selank are and what lab studies report. Research-stage in the U.S.; not FDA approved. Prescription only; provider evaluation required.
• Sermorelin: What It Is and What Research Shows
  What sermorelin is, its history as a GHRH analog, and how a provider decides. Compounded sermorelin is not FDA approved. Prescription only.
• SLU-PP-332
  What SLU-PP-332 is and what a mouse study reported. Preclinical research only; not FDA approved. Prescription only; provider evaluation required.
• SS-31 + MOTS-c + Tesamorelin Blend
  What the SS-31 + MOTS-c + tesamorelin blend contains, what is known about each ingredient, and its safety information. Not FDA approved. Prescription only.
• SS-31
  What SS-31 is, how it is designed to interact with mitochondria, and its regulatory status. Compounded SS-31 is not FDA approved. Prescription only.
• Tesamorelin
  What tesamorelin is, how it acts on the pituitary as a GHRH analog, and its safety information. Compounded tesamorelin is not FDA approved.
• Thymosin Alpha-1
  What thymosin alpha-1 is and what clinical reviews report on immune function. Not FDA approved. Prescription only; provider evaluation required.
• Tirzepatide
  What tirzepatide is, how a dual GIP and GLP-1 agonist works, its labeled side effects, and how compounded versions differ.

Educational content only, not medical advice. Compounded medications are not FDA approved. Prescription only, requires evaluation by a licensed provider.